Showing posts for Vaccine Development

Clear
Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose

Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose

European Medicines Agency recommends conditional marketing authorisation to ChAdOx1 coronavirus vaccine

European Medicines Agency recommends conditional marketing authorisation to ChAdOx1 coronavirus vaccine

Oxford University vaccine developer joins day of vaccinations at the Kassam Stadium

Oxford University vaccine developer joins day of vaccinations at the Kassam Stadium

UK National Health Service begins rollout of Oxford coronavirus vaccine

UK National Health Service begins rollout of Oxford coronavirus vaccine

Oxford vaccine regulatory authorisation: FAQ

Oxford vaccine regulatory authorisation: FAQ

University of Oxford welcomes regulatory authorisation of coronavirus vaccine

University of Oxford welcomes regulatory authorisation of coronavirus vaccine

Oxford vaccine stimulates broad antibody and T cell functions

Oxford vaccine stimulates broad antibody and T cell functions

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Phase 3 trial data publication: FAQ

Phase 3 trial data publication: FAQ

Oxford University breakthrough on global COVID-19 vaccine

Oxford University breakthrough on global COVID-19 vaccine